Document Detail


In ovo DNA immunisation followed by a recombinant fowlpox boost is fully protective to challenge with virulent IBDV.
MedLine Citation:
PMID:  16621184     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this study was to investigate the potential use of DNA vaccination delivered in ovo for protecting against challenge with infectious bursal disease virus (IBDV). Using a plasmid expressing the beta-galactosidase gene, DNA was successfully delivered to the embryo after in ovo injection and localises to the proventriculus and thymus. The coding sequence for the immunogenic IBDV protein, VP2, was cloned into pCI-neo, creating pCI-Vp2. Complete protection against IBDV was obtained by priming in ovo with pCI-Vp2, followed by boosting with the fowlpox recombinant, fpIBD1, also expressing the VP2 gene. This complete protection was not evident with either of the experimental vaccines on their own. An antibody response was not detected after the prime-boost vaccination, even after chicks had been challenged with IBDV, implying that the DNA prime delivered in ovo stimulated a protective cellular immune response.
Authors:
E A Haygreen; P Kaiser; S C Burgess; T F Davison
Related Documents :
18370224 - Electroporation-mediated hbv dna vaccination in primate models.
16253404 - Anti-hbv immune responses in rhesus macaques elicited by electroporation mediated dna v...
2174594 - Genetically engineered vaccines for control of aujeszky's disease (pseudorabies).
16730934 - Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax...
11846364 - A population-based hepatitis b vaccination coverage survey among asian and pacific isla...
3312114 - Periorbital cellulitis.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-04-03
Journal Detail:
Title:  Vaccine     Volume:  24     ISSN:  0264-410X     ISO Abbreviation:  Vaccine     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-06-02     Completed Date:  2006-08-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8406899     Medline TA:  Vaccine     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  4951-61     Citation Subset:  IM    
Affiliation:
Institute for Animal Health, Compton, Berkshire RG20 7NN, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amniotic Fluid / metabolism
Animals
Birnaviridae Infections / immunology,  prevention & control,  veterinary*
Chick Embryo
Chickens
DNA, Recombinant
Deoxyribonucleases / metabolism
Fowlpox virus / immunology*
Immunization, Secondary*
Infectious bursal disease virus / immunology*,  pathogenicity
Poultry Diseases / immunology,  prevention & control*
RNA, Viral / isolation & purification
Vaccines, DNA / administration & dosage,  immunology*
Viral Vaccines / administration & dosage,  immunology*
Virulence
Chemical
Reg. No./Substance:
0/DNA, Recombinant; 0/RNA, Viral; 0/Vaccines, DNA; 0/Viral Vaccines; EC 3.1.-/Deoxyribonucleases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines.
Next Document:  Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mu...